CorMedix (CRMD) is set to report Q2 earnings with revenue estimates of $96.05M and EPS of $0.24, showing negative relative strength and high short interest.
Source Post
CorMedix $CRMD Q2 2026 Earnings Preview
Aug 12, 2026
This is a preview of CorMedix's (CRMD) Q2 2026 earnings report. The company beat revenue estimates in the previous quarter but missed earnings estimates. Current estimates for this quarter are $96.05 million in revenue and $0.24 earnings per share. The stock shows negative relative strength and high short interest, with the options market pricing a significant move.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.